Multiple chemical sensitivity syndrome: Symptom prevalence and risk factors in a military population

Archives of Internal Medicine

Volumn 160, Issue 8, 2000, Pages 1169-1176

  Black, Donald W ^a,b   Doebbeling, Bradley N ^a,b   Voelker, Margaret D ^a   Clarke, William R ^a   Woolson, Robert F ^a   Barrett, Drue H ^c   Schwartz, David A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CHEMICAL SENSITIVITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SOLDIER; SYMPTOMATOLOGY; SYNDROME; UNITED STATES;

EID: 0034709063     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.8.1169     Document Type: Article

References (44)

1. NIH Technology Assessment Workshop Panel. The Persian Gulf experience and health. JAMA. 1994;272:391-396.
2. Persian Gulf Veterans Coordinating Board. Unexplained illnesses among Desert Storm veterans: a search for causes, treatment, and cooperation. Arch Intern Med. 1995;155:262-268.
3. Committee to Review the Health Consequences of Service During the Persian Gulf War. Health Consequences of Service During the Persian Gulf War: Initial Findings and Recommendations for Immediate Action. Washington, DC: American Academy Press; 1994.
4. Iowa Persian Gulf Study Group. Self-reported illness and health status among Gulf War veterans: a population-based study. JAMA. 1997;277:238-245.
5. Miller CS. White paper: chemical sensitivity: history and phenomenology. Toxicol Ind Health. 1994;10:253-313.
6. Miller L. Toxic trauma and chemical sensitivity: clinical syndromes and psychotherapeutic strategies. Psychotherapy. 1995;32:648-656.
7. American College of Physicians. Clinical ecology: position statement. Ann Intern Med. 1989;111:168-178.
8. American College of Occupational and Environmental Medicine. Statement on multiple chemical sensitivities. Approved April 27, 1993.
9. American Medical Association. Report of the Council on Scientific Affairs: clinical ecology. JAMA. 1992;268:3465-3467.
10. Black DW, Rathe A, Goldstein RB. Environmental illness: a controlled study of 26 subjects with "20th century disease." JAMA. 1990;264:3166-3170.
11. Meggs WJ, Dunn KA, Bloch RM, et al. Prevalence and nature of allergy and chemical sensitivity in a general population. Arch Environ Health. 1996;51:275-282.
12. Bell IR, Peterson JM, Schwartz GE. Medical histories and psychological profiles of middle-aged women with and without self-reported illness from environmental chemicals. J Clin Psychiatry. 1995;56:151-160.
13. Levin AS, Byers VS. Multiple chemical sensitivities: a practicing clinician's point of view: clinical and immunologic research findings. Toxicol Ind Health. 1992; 8:95-109.
14. Bell IR. Neuropsychiatric and Biopsychosocial Mechanisms in Multiple Chemical Sensitivity: An Olfactory-Limbic System Model in Multiple Chemical Sensitivities. Washington, DC: National Academy Press; 1992:89-108.
15. Rea WJ, Johnson AR, Ross GH, et al. Considerations for the diagnosis of chemical sensitivity. In: Multiple Chemical Sensitivities. Washington, DC: National Academy Press; 1992:169-192.
16. Ziem GE. Multiple chemical sensitivity: treatment and follow-up with avoidance and control of chemical exposures. Toxicol Ind Health. 1992;8:73-86.
17. Dismukes WE, Wade JS, Lee JY, Dockery BK, Hain JD. A randomized, double-blind trial of nystatin therapy for the candidiasis hypersensitivity syndrome. N Engl J Med. 1990;323:1717-1723.
18. IPCS (International Programme on Chemical Safety). Conclusions and recommendations of a workshop on "multiple chemical sensitivities (MCS)," Feb. 21-23, Berlin, Germany. Regul Toxicol Pharmacol. 1996;24(suppl):S188-S189.
19. Black DW, Doebbeling BN, Voelker MD, et al. Quality of life and health-services utilization in a population-based sample of military personnel reporting multiple chemical sensitivities. J Occup Environ Med. 1999;41:928-933.
20. Spitzer RL, Williams JBW, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders and primary care: the PRIME-MD 1000 study. JAMA. 1994;272:1749-1756
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
22. Weathers F, Litz BT, Heran DS, Huska JA, Kean TM. The PTSD Checklist (PCL): reliability, validity, and diagnostic utility. Paper presented at: Meeting of the International Society of Traumatic Stress Studies; October 1993; San Antonio, Tex.
23. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984;252:1905-1907.
24. Bergner N, Bobbitt RA, Kressel S, et al. The Sickness Impact Profile: conceptual formulation and methodology for the development of the Hill Status Measure. Int J Health Serv. 1976;6:393-415.
25. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res. 1993;37:147-153.
26. Shah BV, Barnwell BG, Bieler GS. SUDAAN Users Manual: Software for Analysis of Correlated Data, Release 6.40. Research Triangle Park, NC: Research Triangle Institute; 1992.
27. SAS Institute Inc. SAS/IML Software: Usage and Reference, Version 6. Cary, NC: SAS Institute Inc; 1990.
28. Cullen MR. The worker with multiple chemical sensitivities: an overview. Occup Med. 1987;2:655-661.
29. Kipen HM, Halman W, Kelly-McNeil K, Fiedler N. Measuring chemical sensitivity prevalence: a questionnaire for population studies. Am J Public Health. 1995; 85:574-577.
30. Kreutzer R, Neutra RR, Lashuay N. Prevalence survey of people reporting sensitivities to chemicals in a population-based survey. Am J Epidemiol. 1999;150: 1-12.
31. Stewart DE, Raskin J. Psychiatric assessment of patients with "20th century disease" ("total allergy syndrome"). CMAJ. 1985;133:1001-1006.
32. Simon GE, Daniell W, Stockbridge H, et al. Immunologic, psychological, and neurological factors in multiple chemical sensitivity: a controlled study. Arch Intern Med. 1993;119:97-102.
33. Fiedler N, Kipen HM, DeLuca J, et al. A controlled comparison of multiple chemical sensitivities and chronic fatigue syndrome. J Occup Med. 1992;52:529-538.
34. Lax MB, Henneberger PK. Patients with multiple chemical sensitivities in an occupational health clinic: presentation and follow-up. Arch Environ Health. 1995; 50:425-431.
35. Bolla-Wilson K, Wilson RJ, Bleeker ML. Conditioning of physical symptoms after neurotoxic exposure. J Occup Med. 1988;30:684-686.
36. Terr AI. Multiple chemical sensitivity syndrome. Occup Asthma Allergies. 1992; 12:897-908.
37. Leznoff A. Provocative challenges in patients with multiple chemical sensitivity. J Allergy Clin Immunol. 1997;99:438-442.
38. Binkley KE, Kutcher S. Panic response to sodium lactate infusion in patients with multiple chemical sensitivity syndrome. J Allergy Clin Immunol. 1997;99:570-574.
39. Shusterman DJ, Dager SR. Prevention of psychological disability after occupational respiratory exposures. Occup Med. 1991;6:11-27.
40. Black DW, Rathe A, Goldstein RB. Measures of distress in 26 "environmentally ill" subjects. Psychosomatics. 1993;34:131-138.
41. Rosenberg SJ, Freedman MR, Schmaling KB, et al. Personality styles of patients asserting environmental illness. J Occup Med. 1990;32:678-681.
42. Fukuda K, Nisenbaum R, Stewart G, et al. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA. 1998;280:981-988.
43. Coughlin SS. Recall bias in epidemiologic studies. J Clin Epidemiol. 1990;43: 87-91.
44. Black DW. Iatrogenic (physician-induced) hypochondriasis: four patient examples of "chemical sensitivity." Psychosomatics. 1996;4:390-393.